Skip to main content
. 2023 Nov 23;10:1276502. doi: 10.3389/fmed.2023.1276502

Table 2.

Variation of functional parameters during the follow-up (n = 23).

Parameters* Follow-up
Pre 1 month 3 months 6 months p^
BCVA 0.98 ± 0.21 0.65 ± 0.31 0.51 ± 0.29 0.47 ± 0.31 <0.0001
RS 11.46 ± 4.91 12.23 ± 4.33 12.80 ± 4.34 13.29 ± 4.40 0.003
CRS 8.40 ± 4.76 9.38 ± 5.01 10.14 ± 4.69 11.24 ± 4.89 0.002
MD −7.69 ± 4.64 −7.01 ± 3.97 −6.31 ± 4.07 −5.99 ± 4.28 0.03
BCEA 68.2% 5.89 ± 6.93 4.56 ± 5.23 4.12 ± 5.66 4.13 ± 5.78 0.18
BCEA 95.4% 14.30 ± 16.83 9.75 ± 8.51 9.39 ± 9.33 8.39 ± 8.17 0.15
BCEA 99.6% 21.41 ± 24.45 17.10 ± 12.12 15.44 ± 12.16 14.85 ± 10.99 0.05

*Mean and Standard Deviation (M ± SD) for continuous variables. BCVA, Best Corrected Visual Acuity; BCEA, Bivariate Contour Ellipse Area; RS, Retinal Sensitivity; MD, Mean Deviation; CRS, Central Retinal Sensitivity. ^Friedman’s test.